DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2007 archives
Click here to return to the current data set

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: tacrolimus

Summary for Generic Name: tacrolimus

Tradenames:2
Patents:0
Applicants:1
NDAs:3
Drug Master File Entries: see list16
Suppliers: see list6
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details

Pharmacology for Ingredient: tacrolimus

Clinical Trials for: tacrolimus

A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation Year
Status: Not yet recruiting Condition: Liver Transplantation

A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)
Status: Not yet recruiting Condition: Renal Transplantation

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients
Status: Completed Condition: Liver Transplantation

A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients
Status: Completed Condition: Liver Transplantation

A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation
Status: Recruiting Condition: Liver Transplantation

A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAF
Status: Completed Condition: Kidney Transplantation

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients
Status: Completed Condition: Kidney Transplantation

Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients
Status: Completed Condition: Liver Transplantation

Prograf-Advagraf Cross Over Conversion Study
Status: Recruiting Condition: Kidney-Pancreas Transplantation

Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant
Status: Recruiting Condition: Transplantation Infection; Cytomegalovirus Infections

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Patented / Exclusive Use
Astellas
PROGRAF
tacrolimus
CAPSULE; ORAL050708Apr 8, 1994RXNo<disabled>ORPHAN DRUG EXCLUSIVITY
Astellas
PROGRAF
tacrolimus
CAPSULE; ORAL050708Apr 8, 1994RXYes<disabled>ORPHAN DRUG EXCLUSIVITY
Astellas
PROGRAF
tacrolimus
CAPSULE; ORAL050708Aug 24, 1998RXNo<disabled>ORPHAN DRUG EXCLUSIVITY
Astellas
PROGRAF
tacrolimus
INJECTABLE; INJECTION050709Apr 8, 1994RXYes<disabled>ORPHAN DRUG EXCLUSIVITY
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc